137 related articles for article (PubMed ID: 21478259)
1. Embryonic catalase protects against endogenous and phenytoin-enhanced DNA oxidation and embryopathies in acatalasemic and human catalase-expressing mice.
Abramov JP; Wells PG
FASEB J; 2011 Jul; 25(7):2188-200. PubMed ID: 21478259
[TBL] [Abstract][Full Text] [Related]
2. Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress.
Abramov JP; Wells PG
Toxicol Sci; 2011 Apr; 120(2):428-38. PubMed ID: 21252394
[TBL] [Abstract][Full Text] [Related]
3. Embryonic catalase protects against ethanol embryopathies in acatalasemic mice and transgenic human catalase-expressing mice in embryo culture.
Miller-Pinsler L; Wells PG
Toxicol Appl Pharmacol; 2015 Sep; 287(3):232-9. PubMed ID: 26074427
[TBL] [Abstract][Full Text] [Related]
4. Embryonic catalase protects against ethanol-initiated DNA oxidation and teratogenesis in acatalasemic and transgenic human catalase-expressing mice.
Miller L; Shapiro AM; Wells PG
Toxicol Sci; 2013 Aug; 134(2):400-11. PubMed ID: 23733920
[TBL] [Abstract][Full Text] [Related]
5. Altered methanol embryopathies in embryo culture with mutant catalase-deficient mice and transgenic mice expressing human catalase.
Miller L; Wells PG
Toxicol Appl Pharmacol; 2011 Apr; 252(1):55-61. PubMed ID: 21295602
[TBL] [Abstract][Full Text] [Related]
6. Protective role of endogenous catalase in baseline and phenytoin-enhanced neurodevelopmental and behavioral deficits initiated in utero and in aged mice.
Abramov JP; Tran A; Shapiro AM; Wells PG
Reprod Toxicol; 2012 Jun; 33(3):361-73. PubMed ID: 22342499
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
Winn LM; Wells PG
Mol Pharmacol; 1995 Jul; 48(1):112-20. PubMed ID: 7623765
[TBL] [Abstract][Full Text] [Related]
8. Methanol teratogenicity in mutant mice with deficient catalase activity and transgenic mice expressing human catalase.
Siu MT; Wiley MJ; Wells PG
Reprod Toxicol; 2013 Apr; 36():33-9. PubMed ID: 23207165
[TBL] [Abstract][Full Text] [Related]
9. Variable in vivo embryoprotective role for ataxia-telangiectasia-mutated against constitutive and phenytoin-enhanced oxidative stress in atm knockout mice.
Bhuller Y; Jeng W; Wells PG
Toxicol Sci; 2006 Sep; 93(1):146-55. PubMed ID: 16714389
[TBL] [Abstract][Full Text] [Related]
10. A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
Bhuller Y; Wells PG
Toxicol Sci; 2006 Sep; 93(1):156-63. PubMed ID: 16790486
[TBL] [Abstract][Full Text] [Related]
11. The peroxynitrite pathway in development: phenytoin and benzo[a]pyrene embryopathies in inducible nitric oxide synthase knockout mice.
Kasapinovic S; McCallum GP; Wiley MJ; Wells PG
Free Radic Biol Med; 2004 Dec; 37(11):1703-11. PubMed ID: 15528029
[TBL] [Abstract][Full Text] [Related]
12. Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress.
Kennedy JC; Memet S; Wells PG
Mol Pharmacol; 2004 Sep; 66(3):404-12. PubMed ID: 15322231
[TBL] [Abstract][Full Text] [Related]
13. Oxidative damage in chemical teratogenesis.
Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
[TBL] [Abstract][Full Text] [Related]
14. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
Sivan E; Lee YC; Wu YK; Reece EA
Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
[TBL] [Abstract][Full Text] [Related]
15. UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin.
Kim PM; Winn LM; Parman T; Wells PG
J Pharmacol Exp Ther; 1997 Jan; 280(1):200-9. PubMed ID: 8996197
[TBL] [Abstract][Full Text] [Related]
16. Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 mice.
Ozolins TR; Siksay DL; Wells PG
J Pharmacol Exp Ther; 1996 May; 277(2):945-53. PubMed ID: 8627577
[TBL] [Abstract][Full Text] [Related]
17. Decreased catalase activity in malformation-prone embryos of diabetic rats.
Cederberg J; Eriksson UJ
Teratology; 1997 Dec; 56(6):350-7. PubMed ID: 9485544
[TBL] [Abstract][Full Text] [Related]
18. Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E.
Chen CS; Wells PG
Carcinogenesis; 2006 Jul; 27(7):1358-68. PubMed ID: 16401638
[TBL] [Abstract][Full Text] [Related]
19. Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species.
Wells PG; Bhuller Y; Chen CS; Jeng W; Kasapinovic S; Kennedy JC; Kim PM; Laposa RR; McCallum GP; Nicol CJ; Parman T; Wiley MJ; Wong AW
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):354-66. PubMed ID: 16081118
[TBL] [Abstract][Full Text] [Related]
20. Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity.
Winn LM; Wells PG
Free Radic Biol Med; 1999 Feb; 26(3-4):266-74. PubMed ID: 9895216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
